Medical Device News Magazine

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Markets 2022-2027

Focus on ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, & Cardiac Output Monitoring Devices

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Others), By Cardiac Rhythm Management Devices, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.

The global cardiac monitoring & cardiac rhythm management devices market is expected to grow at a steady CAGR in the forecast period, 2023-2027

Factors such as the rise in the number of patients suffering from cardiovascular disorders and the growing geriatric population are driving the demand for the global cardiac monitoring & cardiac rhythm management devices market.

Emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market, which is driven by their large and growing population as well as the increasing number of hospitals and clinics in these countries.

The global cardiac monitoring & cardiac rhythm management devices market is segmented into cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution.

Based on cardiac monitoring devices, the market is segmented into ECG devices, implantable loop recorders, mobile cardiac telemetry devices, cardiac output monitoring devices, and others. ECG devices dominate the market and are expected to maintain their dominance through the next five years.

Growing commercialization of novel products, regional expansions, technological advancements, and government initiatives are the primary factors driving the segment demand.

Based on cardiac rhythm management devices, the market is divided into defibrillators and pacemakers. Defibrillators are expected to hold the largest market share in the forecast period, 2023-2027. The surge in the use of cardiac rhythm management devices in countries such as China and India, among others, is influencing the segmental demand.

Companies are focusing on extensive research and development activities to stay competitive in the market.

Objective of the Study:

  • To analyze historical growth in market size of global cardiac monitoring & cardiac rhythm management devices market from 2017 to 2021
  • To estimate and forecast the market size of global cardiac monitoring & cardiac rhythm management devices market from 2022E to 2027F and growth rate until 2027F
  • To classify and forecast global cardiac monitoring & cardiac rhythm management devices market based on cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution
  • To identify dominant region or segment in the global cardiac monitoring & cardiac rhythm management devices market
  • To identify drivers and challenges for global cardiac monitoring & cardiac rhythm management devices market
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cardiac monitoring & cardiac rhythm management devices market
  • To identify and analyze the profiles of leading players operating in global cardiac monitoring & cardiac rhythm management devices market
  • To identify key sustainable strategies adopted by market players in global cardiac monitoring & cardiac rhythm management devices market

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cardiac monitoring & cardiac rhythm management devices market.

  • Abbott Laboratories, Inc
  • Medtronic PLC
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • GE Healthcare
  • Koninklijke Philips NV
  • Hill-Rom Holdings, Inc
  • BIOTRONIK
  • Asahi Kasei Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Alivecor, Inc
  • Metrax GmbH
  • Shenzhen Mindray Bio-Medical Electronics
  • LivaNova PLC

Report Scope:

Years considered for this report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022E
  • Forecast Period: 2023F-2027F

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices:

  • ECG Devices
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry Devices
  • Cardiac Output Monitoring Devices
  • Others

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Rhythm Management Devices:

  • Defibrillators
  • Pacemakers

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User:

  • Hospitals & Clinics
  • Cardiac Care Centers
  • Ambulatory Surgery Centers
  • Others

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region:

  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”